Toxicity of the mycotoxin ochratoxin A in the light of recent data

Toxin Reviews

Volumn 32, Issue 2, 2013, Pages 19-33

  Malir, Frantisek ^a   Ostry, Vladimir ^b   Novotna, Eva ^c,d  

^a UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c UNIVERSITY OF PARDUBICE   (Czech Republic)

^d Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Exposure; Human health; Metabolites; Ochratoxin A; Toxicity

Indexed keywords

BIOLOGICAL MARKER; OCHRATOXIN;

ACUTE TOXICITY; ASPERGILLUS; CARCINOGENESIS; CHEMICAL STRUCTURE; CHRONIC TOXICITY; DIETARY INTAKE; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; GENOTOXICITY; HEALTH HAZARD; IMMUNOTOXICITY; LIVER TOXICITY; METABOLISM; MUTAGENICITY; NEPHROTOXICITY; NEUROTOXICITY; PENICILLIUM; REVIEW; SEX DIFFERENCE; SPECIES DIFFERENCE; TERATOGENICITY; TOXICOKINETICS;

EID: 84877279583     PISSN: 15569543     EISSN: 15569551     Source Type: Journal    
DOI: 10.3109/15569543.2013.782504     Document Type: Review

References (203)

1. Al-Anati L, Petzinger E. (2006). Immunotoxic activity of ochratoxin A. J Vet Pharmacol Ther 29:79-90. (Pubitemid 43332388)
2. Ali R, Mittelstaedt RA, Shaddock JG, et al. (2010). Micronucleus induction by ochratoxin A in CH9 and TK6 cells. Environ Mol Mutagen 51:728.
3. Ali R, Mittelstaedt RA, Shaddock JG, et al. (2011). Comparative analysis of micronuclei and DNA damage induced by oxchratoxin A in two mammalian cell lines. Mutat Res 723:58-64.
4. Arbillaga L, Azqueta A, Ezpeleta O, de Cerain AL. (2007a). Oxidative DNA damage induced by ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity. Mutagenesis 22: 35-42. (Pubitemid 46058639)
5. Arbillaga L, Azqueta A, van Delft JHM, de Cerain AD. (2007b). In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol Appl Pharmacol 220:216-24. (Pubitemid 46507575)
6. Arlt VM, Pfohl-Leskowicz A, Cosyns J, Schmeiser HH. (2001). Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res 494:143-50. (Pubitemid 32566290)
7. Assaf H, Azouri H, Pallardy M. (2004). Ochratoxin A induces apoptosis in human lymphocytes through down regulation of Bcl-xl. Tox Sci 79: 335-44. (Pubitemid 38786891)
8. Austwick PK. (1981). Balkan nephropathy. Practitioner 225:1031-8. (Pubitemid 11041396)
9. Aydin G, Ozcelik N, Cicek E, Soyoz M. (2003). Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats. Hum Exp Tox 22:383-91. (Pubitemid 36987232)
10. Azpilicueta CA, Arbeloa MI, de Maquirriain PFJ. (2008). Natural and syntethic occurring forms of the ochratoxins. In: Papadopoulos KN, ed. Food chemistry research developments. New York: Nova Science Publishers, 116.
11. Bakker M, Pieters MN. (2002). Risk assessment of ochratoxin A in the Netherlands. Report No. 388802025/2002. Bilthoven (the Netherlands): RIV.M.
12. Battilani P, Pietri VA, Giorni P, et al. (2007). Penicillium populations in dry-cured ham manufacturing plants. J Food Prot 70:975-80. (Pubitemid 46608817)
13. Benesic A, Mildenberger S, Gekle M. (2000). Nephrotoxigenic ochratoxin A interferes with mitochondrial function and pH homeostasis in immortalized human kidney epithelial cells. Eur J Physiol 439:278-87. (Pubitemid 30056904)
14. Berger V, Gabriel A-F, Sergent T, et al. (2003). Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistence -Associated protein (MRPZ). Tox Lett 140-141: 465-76. (Pubitemid 36378966)
15. Bonvehi JS. (2004). Occurrence of ochratoxin A in cocoa products and chocolate. J Agric Food Chem 52:6347-52.
16. Bogs C, Battilani P, Geisen R. (2006). Development of a molecular detection and differentiation system for ochratoxin A producing Penicillium species and its application to analyse the occurrence of Penicillium nordicum in cured meats. Int J Food Microbiol 107:39-47. (Pubitemid 43220148)
17. Bolt HM, Degen GH. (2004). Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis. Toxicol Sci 81:3-6. (Pubitemid 39199857)
18. Bolt HM, Foth H, Hengstler JG, Degen GH. (2004). Carcinogenicity categorization of chemicals -new aspects to be considered in a European perspective. Toxicol. Lett 151:29-41. (Pubitemid 38739025)
19. Breitholtz-Emanuelsson A, Olsen M, Oskarsson A, et al. (1993). Ochratoxin A in cow's milk and in human milk with corresponding human blood samples. J AOAC Int 76:842-6.
20. Brera C, Caputi R, Miraglia M, et al. (2002). Exposure assessment to mycotoxins in workplaces: aflatoxins and ochratoxin A occurrence in airborne dusts and human sera. Microchem J 73:167-73.
21. Bullerman LB, Bianchini A. (2007). Stability of mycotoxins during food processing. Int J Food Microbiol 119:140-6. (Pubitemid 350051477)
22. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, et al. (1989). Sex and Strain-specific induction of renal tumours by ochratoxin A rats correlates with DNA adduction. International J. Cancer 77:70-75.
23. Castegnaro M, Canadas D, Vrabcheva T, et al. (2006). Balkan endemic nephropathy: role of ochratoxins A through biomarkers. Mol Nutr Food Res 50:519-529. (Pubitemid 43944161)
24. Capdevila JH, Falck JR, Harris RC. (2000). Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachid onate monooxygenase. J Lipid Res 41:163-81. (Pubitemid 30117856)
25. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, et al. (1998). Sex-And strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Inter J Cancer 77:70-5. (Pubitemid 28308554)
26. Cavin Ch, Delatour T, Kuan MM, et al. (2009). Ochratoxin A-mediated DNA and protein damage: roles of nitrosative and oxidative stresses. Toxicol Sci 110:84-94.
27. Chandrasekharan NV, Dai H, Roos KL, et al. (2002). COX-3, a cyclooxygenase variant inhibited by acetaminophen and other analgesic/ antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-31. (Pubitemid 35215482)
28. Chopra M, Link P, Michels C, Schrenk D. (2010). Characterization of ochratoxin A -induced apoptosis in primary rat hepatocytes. Cell Biol Toxicol 26:239-54.
29. Chu FS. (1971). Interaction of ochratoxin A with bovine serum albumine. Arch Biochem Biophys 147:359-66.
30. Chu FS. (1974). A comparative study of the interaction of ochratoxins with bovine serum albumine. Biochem Pharmacol 23:1105-7.
31. Clark HA, Snedeker SM. (2006). Ochratoxin A: its cancer risk and potential for exposure. J Toxicol Environ Health B Crit Rev 9:265-96.
32. Cramer B, Harrer H, Nakamura K, et al. (2010). Total synthesis and cytotoxicity evaluation of all ochratoxin A stereoisomers. Bioorg Med Chem 18:343-7.
33. Creppy EE, Chiarappa P, Baudrimont I, et al. (2004). Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity? Toxicology 201:115-23. (Pubitemid 39023939)
34. Czakai K, Muller K, Mosesso P, et al. (2011). Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin A toxicity and carcinogenicity? Tox Sci 122:317-29.
35. Dai J, Park G, Wright MW, et al. (2002). Detection and characterization of a glutathione conjugate of ochratoxin A. Chem Res Toxicol 15: 1581-8. (Pubitemid 36008205)
36. Dai J, Wright MW, Manderville RA. (2003). Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: implications for C8 reactivity by a phenolic radical. J Am Chem Soc 125:3716-17. (Pubitemid 36512356)
37. Dall'Asta Ch, Galaverna G, Dossena A, et al. (2010). Masked mycotoxins and mycotoxin derivatives in food: the hidden menace. In: Rai M, Varma A, eds. Mycotoxins in food, feed and bioweapons. Berlin-Heidelberg: Springer-Verlag, 385-97.
38. De Almeida AP, Alaburda J, Shundo L, et al. (2007). Ochratoxin A in Brazilian instant coffee. Braz J Microbiol 38:300-3. (Pubitemid 47037422)
39. Degen GH, Mayer S, Blaszkevicz M. (2007). Biomonitoring of ochratoxin A in grain workers. Mycotox Res 23:88-93.
40. Delatour T, Mally A, Richoz J, et al. (2008). Absence of 20-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol Nutr Food Res 52:472-82.
41. Di Paolo G, Guarnieri A, Garosi G, et al. (1994). Inhaled mycotoxins lead to acute renal failure. Nephrol Dial Transplant 9:116-20. (Pubitemid 24249484)
42. Dimitrov P, Tsolova S, Deorgieva R, et al. (2006). Clinical markers in adult offspring of families with and without Balkan Endemic Nephropathy. Kidney Int 69:723-9. (Pubitemid 43237642)
43. Domijan A-M, Rudes K, Peraica M. (2005). The effect of ochratoxin A on the concentration of protein carbonyls in rats. Arh Hig Rada Toksikol 56:311-15. (Pubitemid 41789622)
44. Domijan AM, Teljetic D, Kopjar N, Peraica M. (2006). Standard and Fpg-modified comet assay in kidney cells of ochratoxin A-And fumonisin B1-treated rats. Toxicology 222:53-9.
45. Duarte SC, Pena A, Lino CM. (2009). Ochratoxin A non-conventional exposure sources. Microchem J 93:115-20.
46. Duarte SC, Pena A, Lino CM. (2011). Human ochratoxin a biomarkers -from exposure to effect. Crit Rev Toxicol 41:187-212.
47. EFSA. (2006). Opinion of the scientific panel on contaminants in the food chain on request from the commission related to ochratoxin A in food. EFSA J 365:1-56.
48. Ehrlich V, Darroudi F, Uhl M, et al. (2002). Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem Toxicol 40:1085-90. (Pubitemid 34626871)
49. El Adlouni C, Pinelli E, Azemar B, et al. (2000). Role of CYP 2C and microsomal glutathione-S-transferase in modulating susceptibility to ochratoxin A genotoxicity. Environ Mol Mutagen 35:123-31. (Pubitemid 30171821)
50. Erkekoglu P, Sabuncuoglu S, Aydin S, et al. (2010). Determination of seasonal variations in serum ochratoxin A levels in healthy population living in some regions of Turkey by enzyme-linked immunosorbent assay. Toxicon 55:507-13.
51. FAO/WHO (Food and Agriculture Organisation/World Health Organisation). (2001). Ochratoxin A. In: Safety evaluation of certain mycotoxins in food, Prepared by the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series 47. Geneva, Switzerland: World Health Organisation, 281-387.
52. Faucet V, Pfohl-Leszkowicz A, Dai J, et al. (2004). Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol 17:1289-96. (Pubitemid 39265886)
53. Faucet-Marquis V, Pont F, Størmer FC, et al. (2006). Evidence of a new dechlorinated OTA derivative formed in opossum kidney cell cultures after pre-treatment by modulators of glutathione pathways. Correlation with DNA adducts formation. Mol Nutr Food Res 50: 530-42. (Pubitemid 43944162)
54. Faucet-Marquis V, Tozlovanu M, Richard A, et al. (2008). Evidence by LC MS/MS of the presence of 20deoxyguanosine-carbon 8-bound ochratoxin A in kidney DNA of rat fed OTA. EEMS 38th Annual Meeting, Environmental Mutagens and Health; 2008 Sept 21-25; Cavtat, Program and Abstracts, 131.
55. Follmann W, Hillebrand IE, Creppy EE, Bold HM. (1995). Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated by OTA and alpha OTA. Arch Toxicol 69:280-6.
56. Follmann W, Lucas S. (2003). Effects of the mycotoxin ochratoxin A in a bacterial and mammalian in vitro mutagenicity test systém. Arch Toxicol 77:298-304. (Pubitemid 36714077)
57. Frisvad JC, Frank JM, Houbraken J AMP, et al. (2004). New ochratoxin A producing species of Aspergillus section Circumdati. Studies in Mycology 50:23-43.
58. Fuchs R, Peraica M. (2005). Ochratoxin A in human kidney diseases. Food Addit Contam 22:53-7. (Pubitemid 44574574)
59. Gareis M, Martlbauer E, Bauer J, Gedek B. (1988). Determination of ochratoxin A in human milk. Z Lebensm Unters Forsch 186:114-17. (Pubitemid 18090507)
60. Gautier JC, Richoz J, Welti DH, et al. (2001). Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes. Chem Res Toxicol 14:34-45. (Pubitemid 32064373)
61. Gekle M, Sauvant C, Schwerdt G. (2005). Ochratoxin A at nanomolar concentrations: a signal modulator in renal cells. Mol Nutr Food Res 49:118-30. (Pubitemid 40379811)
62. Grollman AP, Jelakovic B. (2007). Role of environmental toxins in endemic (Balkan) nephropathy. J Am Soc Nephrol 18:2817-23. (Pubitemid 350064082)
63. Gross-Steinmeyer K, Weymann J, Hege HG, Metzler M. (2002). Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes. J Agric food Chem 50:938-45. (Pubitemid 34163649)
64. Grosse Y, Castegnaro M, Macé K, et al. (1995). Evaluation of ochratoxin A genotoxicity by DNA-Adducts detection: cytochromes P450 implicated. Clin Chem 12:1927-9.
65. Grosse Y, Monje MC, Macé K, et al. (1997). Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A. In vitro Toxicol 10:93-102.
66. Grosso F, Said S, Mabrouk I, et al. (2003). New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 41:1133-40. (Pubitemid 36782518)
67. Hadjeba-Medjdoub K, Tozlovanu M, Pfohl-Leszkowicz A, et al. (2012). Structure-Activity relationship imply different mechanisms of action for ochratoxin A-mediated cytotoxicity and genotoxicity. Chem Res Toxicol 25:181-90.
68. Haighton LA, Lynch BS, Magnuson BA, Nestmann ER. (2012). A reassessment of risk associated with dietary intake of ochratoxin A based on lifetime exposure model. Crit Rev Toxicol 42:147-68.
69. Halstensen AS, Nordby KC, Elen O, Eduard W. (2004). Ochratoxin in grain dust-estimated exposure and relations to agricultural practices in grain production. Ann Agric Environ Med 11:245-54. (Pubitemid 40065252)
70. Hassen W, Abid S, Achour A, et al. (2004). Ochratoxin A and beta 2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposure. Toxicol 199:185-93. (Pubitemid 38624529)
71. Henning A, Fink-Gremmels J, Leistner L. (1991). Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation. In: Castegnaro M, Plestina R, Dirheimer G, et al, eds. Mycotoxins, endemic nephropathy and urinary track tumors. Lyon: IARC Sci. Publ., 115, 255-60.
72. Heussner AH, Dietrich DR, O'Brien E. (2006). In vitro investigation of individual and combined cytotoxin effects of ochratoxin A and other selected mycotoxins on renal cells. Toxicol In Vitro 20:332-41. (Pubitemid 43343763)
73. Hibi D, Suzuki Y, Ishii Y, et al. (2011). Site-specific in vivo mutagenicity in the kidney of gpt delta rats given a carcinogenic dose of ochratoxin A. Toxicol Sci 122:406-14.
74. Iavicoli I, Brera C, Carelli G, et al. (2002). External and internal dose in subjects occupationally exposed to ochratoxin A. Int Arch Occup Environ Health 75:381-6. (Pubitemid 36075128)
75. IARC. (1993). Monographs on the evaluation of carcinogenic risks to humans: some naturally occuring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Vol. 56. Lyon, France: IARC, 489-524.
76. Iyer NG, Ozdag H, Caldas C. (2004). P300/CBP and cancer. Oncogene 23:4225-31. (Pubitemid 38758588)
77. JECFA. (2002). Safety evaluation of certain mycotoxins in food. Fiftysixth Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series, 47; Geneva, 6-15 February, 2001, 1-62.
78. JECFA. (2008). Ochratoxin A in safety evaluation certain food additives and contaminants. Sixty-eighth Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series, Vol. 59; Geneva, Switzerland, 169-80.
79. Jennings-Gee JE, Tozlovanu M, Manderville R, et al. (2010). Ochratoxin A: in utero exposure in mice induces adducts in testicular DNA. Toxins 2:1428-44.
80. Jump BD. (2002). The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 277:8755-8.
81. Kamp HG, Eisenbrand G, Schlatter J, et al. (2005). Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206:413-25. (Pubitemid 39601026)
82. Kuiper-Goodman T, Hilts C, Billiard SM, et al. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam 27:212-40.
83. Lebrun S, Follmann W. (2002). Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay). Arch Toxicol 75:734-41. (Pubitemid 34151160)
84. Lebrun S, Golka K, Schulze H, Follmann W. (2006). Glutathione-S- transferase polymorphisms and ochratoxin A toxicity in primary human urothelial cells. Toxicology 224:81-90.
85. Li S, Marquardt RR, Frohlich AA. (2000). Identification of ochratoxins and some their metabolites in bile and urine rats. Food Chem Toxicol 38:141-52. (Pubitemid 30136265)
86. Lioi MB, Santoro A, Barbieri R, et al. (2004). Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutat Res 557:19-27. (Pubitemid 38045578)
87. Luhe A, Hildebrand H, Bach U, et al. (2003). A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol Sci 73:310-15.
88. Lock EA, Hard GC. (2004). Chemically induced renal tubule tumours in the laboratory rat and mouse: review of the NCI/NTP diabase and categorization of renal carcinogens based on mechanistic information. Crit Rev Toxicol 34:211-99. (Pubitemid 38670039)
89. Malir F, Ostry V, Pfohl-Leszkowicz A, Roubal T. (2012). Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries. Biomarkers 17:577-89.
90. Mally A. (2012). Ochratoxin A and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A. Tox Sci 127: 315-30.
91. Mally A, Decker M, Bekteshi M, Dekant W. (2006). Ochratoxin A alters cell adhesion and gap junction intercellular communication in MDCK cells. Toxicol 223:15-25. (Pubitemid 43728626)
92. Mally A, Dekant W. (2005). DNA adduct formation by ochratoxin A: a review of the available evidence. Food Add Contam Suppl. 1: 65-74. (Pubitemid 44574576)
93. Mally A, Dekant W. (2009). Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res 53:467-78.
94. Mally A, Hard, GC, Dekant W. (2007). Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats. Food Chem Toxicol 45:2254-60. (Pubitemid 47451578)
95. Mally A, Keim-Heusler H, Amberg A, et al. (2005b). Biotransformation and nephrotoxicity of ochratoxin B in rats. Tox and App Pharmacol 206:43-53. (Pubitemid 40800427)
96. Mally A, Pepe G, Ravoori S, et al. (2005a). Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol 18:1253-61. (Pubitemid 41170249)
97. Mally A, Volkel W, Amberg A, et al. (2005c). Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Chem Res Toxicol 18:1242-52. (Pubitemid 41170248)
98. Mally A, Zepnik H, Wanek P, et al. (2004). Ochratoxin A: lack of formation of covalent DNA adducts. Chem Res Toxicol 17:234-42. (Pubitemid 38252503)
99. Manderville RA. (2005). A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem Res Toxicol 18: 1091-7. (Pubitemid 41022841)
100. Manderville RA, Pfohl-Leszkowicz A. (2008). Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycotox J 1:357-67.
101. Mantle PG. (2002). Risk assessment and the importance of ochratoxins. Int Biodeter Biodegr 50:143-6. (Pubitemid 35381026)
102. Mantle PG. (2010). Comments on ''ochratoxin A: in utero exposure in mice induces adducts in testicular DNA. Toxins, 2010, 2, 1428-44
103. mis-citation of rat literature to justify a hypothetical role for ochratoxin A in testicular cancer. Toxins 2, 2333-36.
104. Mantle PG, Faucet-Marquis V, Manderville RA, et al. (2010). Structures of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 23:89-98.
105. Mantle PG, Kulinskaya E. (2010). Lifetime, low-dose ochratoxin A dietary study on renal carcinogenesis in male Fischer rats. Food Addit Contam A 27:1566-73.
106. Mantle PG, Kulinskaya E, Nestler S. (2005). Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit Contam 22:58-64. (Pubitemid 44574575)
107. Marin-Kuan M, Cavin Ch, Delatour T, Schilter B. (2008). Ochratoxin A carcinogenicity involves a complex of network of epigenetic mechanisms. Toxicon 52:195-202.
108. Marin-Kuan M, Ehrlich V, Delatour T, et al. (2011). Evidence for a role of oxidative stress in carcinogenicity of ochratoxin A. J Toxicol 122: 406-14.
109. Marin-Kuan M, Nestler SW, Verguet C, et al. (2006). A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol Sci 89:120-34. (Pubitemid 43013761)
110. Marquardt RR, Frohlich AA. (1992). A review of recent advances in understanding ochratoxicosis. J Anim Sci 70:3968-88.
111. Martins ML, Gimeno A, Martins HM, Bernardo F. (2002). Co-occurrence of patulin and citrinin in Portuguese apples with rotten spots. Food Addit Contam 19:568-74. (Pubitemid 34746277)
112. Martins ML, Martins HM, Gimeno A. (2003). Incidence of microflora and of ochratoxin A in green coffee beans (Coffea arabica). Food Addit Contam 20:1127-31. (Pubitemid 38128502)
113. Mayer S, Engelhart S, Kolk A, Blome H. (2008). The significance of mycotoxins in the framework of assessing workplace related risks. Mycotox Res 24:151-64.
114. Mosesso P, Cinelli S, Pinero J, et al. (2008). In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity. Chem Res Toxicol 21: 1235-43. (Pubitemid 351967388)
115. Mounjouenpou P, Gueule D, Fontana-Tachon A, et al. (2008). Filamentous fungi producing ochratoxin a during cocoa processing in Cameroon. Int J Food Microbiol 121:234-41.
116. Muller G, Burkert B, Moller U, et al. (2004). Ochratoxin A and some of its derivatives modulate radical formation of porcine blood monocytes and granulocytes. Toxicology 199:251-9. (Pubitemid 38624535)
117. Napolitano A, Fogliano V, Tafuri A, Ritieni A. (2007). Natural occurrence of ochratoxin A and antioxidant activities of green and roasted coffees and corresponding byproducts. J Agric Food Chem 55: 10499-504.
118. Nedelko T, Arlt VM, Phillips DH, Hollstein M. (2009). TP53 mutation signature supports involvement of aristolochic acid in the etiology of endemic nephropathy-Associated tumors. Int J Cancer 124:987-90.
119. O'Brien E, Dietrich DR. (2005a). Ochratoxin A: the continuing enigma. Crit Rev Toxicol 35:33-60. (Pubitemid 40179900)
120. O'Brien E, Prietz A, Dietrich DR. (2005b). Investigation of the teratogenic potential of ochratoxin A and B using the FETAX system. Dev Repr Tox 74:417-23. (Pubitemid 41579585)
121. Obrecht-Pflumio S, Chassat T, Dirheimer G, Marzin D. (1999). Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes. Mutat Res 446: 95-102. (Pubitemid 29516664)
122. Obrecht-Pflumio S, Grosse Y, Pfohl-Leszkowicz A, Dirheimer G. (1996). Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney. Archives Toxicol 70:244-8. (Pubitemid 26037744)
123. Olsen M, Jonsson N, Magan N, et al. (2003). Prevention of ochratoxin A in cereals. OTA PREV, 1-256. Available at: http://www.slv.se/upload/dokument/fou/ MIB/FINAL%20REPORT.pdf [last accessed 24 February 2013].
124. Palma N, Cinelli S, Sapora O, et al. (2007). Ochratoxin A-induced mutagenesis in mammalian cells in consistent with the production of oxidative stress. Chem Res Toxicol 20:1031-7. (Pubitemid 47204816)
125. Park DL, Troxell TC. (2002). US perspective on mycotoxin regulatory issues. In: De Vries JW, Trucksess MW, Jackson LS, eds. Mycotoxins and food safety book series: advances in experimental medicine and biology: Volume 504. Wageningen: Kluwer Academic/Plenum Publishers, 117-34.
126. Pepelnjak S, Segvic-Klaric M. (2010). ''Suspects'' in Etiology of endemic nephropathy: aristolochic acid versus mycotoxins. Toxins 2: 1414-27.
127. Perrone G, Mule G, Susca A, et al. (2006). Ochratoxin A production and amplified fragment length polymorphism analysis of Aspergillus carbonarius, Aspergillus tubingensis, and Aspergillus niger strains isolates from grapes in Italy. Appl Environ Microbiol 72:680-5.
128. Petrik J, Zanic-grubisic T, Barisic K, et al. (2003). Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch Toxicol 77:685-93. (Pubitemid 38088027)
129. Petzinger E, Ziegler K. (2000). Ochratoxin A from a toxicological perspective. J Vet Pharmacol Ther 23:91-8. (Pubitemid 30348766)
130. Pfohl-Leszkowicz A. (2009). Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465-83.
131. Pfohl-Leszkowicz A, Bartsch H, Azémar B, et al. (2002b). MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta universitatis, series Medicine & Biology 9:57-63.
132. Pfohl-Leszkowicz A, Castegnaro M. (2005). Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit Contam Suppl 22:75-87. (Pubitemid 44574577)
133. Pfohl-Leszkowicz A, Castegnaro M. (2006). Answer to letter to editor from Dekant on analysis of breakfast cereal. Food Chem 99: 178-81.
134. Pfohl-Leszkowicz A, Chakor K, Creppy EE, Dirheimer G. (1991). DNA adducts formation in mice treated with ochratoxin A. In: Castegnaro M, Plestina R, Dirheimer G, et al, eds. Mycotoxins, endemic nephropathy and urinary tract tumors. Lyon: IARC Sci. Publ., 115, 245-53.
135. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, et al. (1993a). Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. Lyon: IARC Scientific Publications, 141-8.
136. Pfohl-Leszkowicz A, Grabryelski W, Manderville RA. (2009). Formation of 20 deoxyguanosine-carbon-8-bound ochratoxin A adduct in rat kidney DNA. Mol Nutr Food Res 53:154-5.
137. Pfohl-Leszkowicz A, Grosse Y, Kane A, et al. (1993b). Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin, ochratoxin A. Mutation Res 289: 265-73. (Pubitemid 23287937)
138. Pfohl-Leszkowicz A, Manderville RA. (2007). Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61-99. (Pubitemid 46144764)
139. Pfohl-Leszkowicz A, Manderville RA. (2012). An update on direct genotoxicity as a molecular mechanism of ochratoxin A carcinogenicity. Chem Res Toxicol 25:252-62.
140. Pfohl-Leszkowicz A, Molinié A, Tozlovanu M, Manderville RA. (2008). Combined toxic effects of ochratoxin A and citrinin in vitro and in vivo. In: Siantar DP, Truckksess MW, Scott PM, Herman EM, eds. Food contaminants: mycotoxins & food allergen, ACS Symposium series 1001. Washington, DC: American Chemical Society, 56-80.
141. Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. (2002a). Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit Contam 19:282-302. (Pubitemid 34121385)
142. Pfohl-Leszkowicz A, Pinelli E, Bartsch H, et al. (1998). Sex and strain differences in ochratoxin A metabolism and DNA adduction in two strains of rats. Mol Carcinogenesis 23:76-83.
143. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, et al. (2007). New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 51:131-46.
144. Pinelli E, El Adlouni C, Pipy B, et al. (1999). Respective implication of cyclooxygenase and lipoxygenase in ochratoxin A genotoxicity on human epithelial lung cells. Environ Toxicol Pharmacol 7:95-107. (Pubitemid 29221938)
145. Plastina P, Fazio A, Attya M, et al. (2011). Synthesis of analogues of ochratoxin A. Nat Prod Res i:1-7.
146. Polizzi V, Delmuelle B, Adams A, et al. (2009). JEM spotlight: fungi, mycotoxins and microbial volatile organic compounds in mouldy interiors from water -damaged buildings. J Environ Mon 11: 1849-58.
147. Puntaric D, Bosnir J, Smit Z, Baklaic Z. (2001). Ochratoxin A in corn and wheat: geographical association with endemic nephropathy. Croat Med J 42:175-80. (Pubitemid 32525319)
148. Rached E, Hard GC, Blumbach K, et al. (2007). Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats. Toxicol. Sci 97: 288-98. (Pubitemid 47073846)
149. Rached E, Pfeiffer E, Dekant W, Mally A. (2006). Ochratoxin A: apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol Sci 92:78-86. (Pubitemid 43985792)
150. Reddy MV, Randerath K. (1986). Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543-51.
151. Ringot D, Chango A. (2010). Risk assessment of ochratoxin A (OTA). In: Rai M, Varma A, eds. Mycotoxins in food, feed and bioweapons. Berlin-Heidelberg: Springer-Verlag, 307-28.
152. Ringot D, Chango A, Schneider YJ, Larondelle Y. (2006). Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem Biol Interact 19:18-46. (Pubitemid 41773628)
153. Rizzo A, Eskola M, Atroshi F. (2002). Ochratoxin A in cereals, foodstuffs and human plasma. Eur J Plant Pathol 108:631-7. (Pubitemid 35293884)
154. Robbiano L, Baroni D, Carrozzino R, et al. (2004). DNA damage and micronuclei induced in rat and human kidney cells by six chemicals carcinogenic to the rat kidney. Toxicology 204: 187-95. (Pubitemid 39244078)
155. Samson RA, Houbraken JAMP, Kuijpers AFA, et al. (2004). New ochratoxin A or sclerotium producing species in Aspergillus section Nigri. Stud Mycol 50:45-6.
156. Satheesh CC, Sharma AK, Dwivedi P, et al. (2005). Immunosupressive effect of ochratoxin A in Wistar rats. J An Vet Adv 4:603-9.
157. Sava V, Reunova O, Velasquez A, et al. (2006). Acute neurotoxic effects of the fungal metabolite ochratoxin A. Neurotoxicology 27: 82-92. (Pubitemid 41745011)
158. Sava V, Reunova O, Velasquez A, et al. (2007). Adult hippocampal neural stem/progenitor cells in vitro are vulnerable to the mycotoxin ochratoxin-A. Toxicol Sci 98:187-97. (Pubitemid 47073831)
159. Schaaf GJ, Nijmeijer SM, Maas RF, et al. (2002). The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim Biophys Acta 1588:149-58. (Pubitemid 35217838)
160. Schwartz GG. (2002). Hypothesis: does ochratoxin A cause testicular cancer? Cancer Causes Control 13:91-100. (Pubitemid 34163955)
161. Schwartz GG, Manderville RA, Pfohl-Leszkowicz A. (2010). Response to comments of Peter G. Mantle. Toxins 2:2337-9.
162. Schwartz GG, Marquis VF, Genings-Gee J, et al. (2007). Prenatal exposure to ochratoxin A cases DNA adults in the testes of newborn mice. Scand J Urol Nephrol 1:217-20.
163. Schwerdt G, Holzinger H, Sauvant Ch, et al. (2007). Long-term effects of ochratoxin A on fibrosis and cell death in human proximal tubule or fibroblast cells in primary culture. Toxicol 232:57-67. (Pubitemid 46283174)
164. Segvic Klaric M, Darabos D, Rozgaj R., et al. (2010). Beauvericin and ochratoxin A genotoxicity evaluated using the alkaline comet assay: single and combined genotoxic action. Arch Toxicol 84: 641-50.
165. Segvic-Klaric M, Popelnjak S., Domijan AM, Petrik J. (2007b). Lipid peroxidation and glutatione levels in porcine kidney PK 15 cells after individual and combined treatment with fumonisin B1, beauvericin and ochratoxin A. Basic Clin Pharmacol Toxicol 100: 157-64.
166. Segvic-Klaric M, Popelnjak S, Rozgaj R. (2008b). Genotoxicity of fumonisin B1, beauvericin and ochratoxin A in porcine kidney PK 15 cells: effects of individual and combined treatment. Croat Chem Acta 81:139-46.
167. Segvic-Klaric M, Rumora L, Ljubanovic D, Popelnjak S. (2008a). Cytotoxicity and apoptosis induced by fumonisin B1, beauvericin and ochratoxin A in porcine kidney PK 15 cells: effects of individual and combined treatment. Arch Toxicol 82:247-55. (Pubitemid 351661650)
168. Segvic-Klaric M, Zeljezic D, Domijan AM, et al. (2007a). Cytotoxicity, genotoxicity and apoptosis induced by ochratoxin A and citrinin in porcine kidney PK-15 cells: effects of single and combined mycotoxins. Toxicol Lett 172:56-61.
169. Segvic-Klaric M, Zeljezic D, Rumora L, et al. (2012). A potential role of calcium in apoptosis and aberrant chromatin forms in porcine kidney PK15 cells induced by individual and combined ochratoxin A and citrinin. Arch Toxicol 86:97-107.
170. Simarro Doorten AY, Bull J, van der Doelen MAM, Fink-Gremmels J. (2004). Metabolism-mediated cytotoxicity of ochratoxin A. Toxicol in Vitro 18:271-7. (Pubitemid 38376359)
171. Simarro-Doorten Y, Nijmejer S, De Njis-Tjon L, Fink-Gremmels J. (2006). Metabolism-mediated ochratoxin A genotoxicity in the single-cell gel electrophoresis (Comet) assay. Food Chem Toxicol 44:261-70. (Pubitemid 41781984)
172. Skaug MA. (2003). Levels of ochratoxin A and IgG against gonidia of Penicillium verrucosum in blood samples from healthy farm workers. Ann Agric Environ Med 10:73-7. (Pubitemid 36781783)
173. Skaug MA, Eduard W, Størmer FC. (2001). Ochratoxin A in airborne dust and fungal conidia. Mycopathologia 151:93-8 (revised 2006
174. Slade N, Moll UM, Brdar B, et al. (2009). p53 mutations as fingerprints for aristolochic acid: an environmental karcinogen in endemic (Balkan) nephropathy. Mutat Res 663:1-6.
175. Speijers GJA, Speijers MHM. (2004). Combined toxic effects of mycotoxins. Toxicol Lett 153:91-8. (Pubitemid 39165753)
176. Stander AM, Nieuwoudt TW, Steyn PS, et al. (2001b). Toxicokinetics of ochratoxin A in vervet monkeys (Cercopithecus aethiops). Arch Toxicol 75:262-9. (Pubitemid 32702199)
177. Stander M, Steyn PS, Weistuizen FH, Payne BE. (2001a). A kinetic study into the hydrolysis of the ochratoxins and analogues by carboxypeptidase A. Chem Res Toxicol 14:302-4. (Pubitemid 32238490)
178. Stark AA. (2005). Threat assessment of mycotoxins as weapons: molecular mechanism of acute toxicity. J Food Prot 68: 1285-93.
179. Stoev SD, Daskalov H, Radic B, et al. (2002a). Spontaneous mycotoxic nephropathy in Bulgarian chickens with unclarified mycotoxin etiology. Vet Res 33:83-93. (Pubitemid 34173042)
180. Stoev SD, Djuvinov D, Mirtcheva T, et al. (2002b). Studies on some feed additives giving partial protection against ochratoxin A toxicity in chicks. Toxicol Lett 135:33-50. (Pubitemid 35266717)
181. Stoev SD, Stefanov M, Denev S, et al. (2004). Experimental mycotoxicosis in chickens induced by ochratoxin A and penicillic acid and intervention with natural plant extracts. Vet Res Commun 28: 727-46. (Pubitemid 39433636)
182. Studer-Rohr I, Schlatter J, Dietrich DR. (2000). Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol 74:499-510.
183. Sujani NG, Sriraman PK. (2000). Pathology of ochratoxicosis in quails. Indian J Animal Sci 70:1120-2. (Pubitemid 33204595)
184. Timbrell JA. (1998). Biomarkers in toxicology. Toxicology 129:1-12. (Pubitemid 29084427)
185. Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville Richard A. (2006). Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-Activity relationships for covalent DNA adduction. Chem Res Toxicol 19:1241-7. (Pubitemid 44454042)
186. Tozlovanu M, Canadas D, Pfohl-Leszkowicz A, et al. (2012). Glutathione conjugates of ochratoxin A as biomarkers of exposure. Arh Hig Rada Toksikol 63:417-27.
187. Tozlovanu M, Pfohl-Leszkowicz A. (2010). Ochratoxin A in roasted coffee purchased in French super market. Transfer in coffee beverage: comparison of several methods. Toxins 2:1928-49.
188. Turesky RJ. (2005). Perspective: ochratoxin A is not a genotoxic carcinogen. Chem Res Toxicol 18:1082-90. (Pubitemid 41022840)
189. Turnbull C, Rapley EA, Seal S, et al. (2010). Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 42:604-7.
190. Ueta E, Kodama M, Sumino Y, et al. (2010). Gender-dependent differences in the incidence of ochratoxin A-induced neural tube defects in the Pdn/Pdn mouse. Congenital anomalies (Kyoto) 50: 29-39.
191. Van Der Merwe KJ, Steyn PS, Fourie L. (1965a). Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus. Wilh Nature 205: 1112-13.
192. Van Der Merwe KJ, Steyn PS, Fourie L. (1965b). Mycotoxins part II. The constitution of ochratoxins A, B and C, metabolites of Aspergillus ochraceus. Wilh J Chem Soc 204:7083-8.
193. Vaidya VS, Ferguson MA, Bonventre JV. (2008). Biomarkers of acute kidney injury. Ann Rev Pharm Tox 48:463-93. (Pubitemid 351738161)
194. Vrabcheva T, Usleber E, Dietrich R, et al. (2000). Co-occurrence of ochratoxin A and citrinin in cereals from bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem 48: 2483-8. (Pubitemid 30431262)
195. Wang Y, Chai G, Lu G, et al. (2008). Simultaneous detection of airborne aflatoxin, ochratoxin and zearalenone in a poultry house by immunoaffinity clean-up and high performance liquid chromatography. Environ Res 107:139-44.
196. Weber F, Freudinger R, Schwerdt G, Gekle M. (2005). A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substances. Toxicol In Vitro 19:135-45.
197. Weidenbach A, Petzinger E. (2004). Ochratoxin A: toxicology of an abundant mycotoxin. Curr Topics Pharmacol 8:235-50.
198. Wu Q, Dohnal V, Huang L, et al. (2011). Metabolic pathways of ochratoxin A. Curr Drug Metab 12:1-10.
199. Yordanova P, Wilfried K, Tsolova S, Dimitrov P. (2010). OchratoxinAand b-2 microglobulin in BEN patients and controls. Toxins 2:780-92.
200. Zeljezic D, Domijan AM, Peraica M. (2006). DNA damage by ochratoxin A in rat kidney assessed by the alkaline comet assay. Braz J Med Biol Res 39:1563-8. (Pubitemid 46357841)
201. Zepnik H, Pahler A, Schauer U, Dekant W. (2001). Ochratoxin Ainduced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol Sci 59:59-67. (Pubitemid 32117981)
202. Zepnik H, Volkel W, Dekant W. (2003). Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol Appl Pharmacol 192:36-44. (Pubitemid 37205116)
203. Zurich M-G, Lengacher S, Braissant O, et al. (2005). Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. Neurosci 134:771-82. (Pubitemid 41133381)